Medical specialists from Finland tagged as investigators in clinical trials studying Leukemia, Myeloid, Acute
Total 30 results
-
Anna-Leena HuuskoSeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Annasofia HolopainenSeen in:
- Kuopio, Kuopio University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Antti TurunenSeen in:
- Kuopio, Kuopio University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Anu PartanenSeen in:
- Kuopio, Kuopio University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Jenni PylkäsSeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Johanna RimpiläinenSeen in:
- Tampere, FI-Tampere-TAYS
- Tampere, Tampere University Hospital
Trials:- NCT04027309 (Principal Investigator)
- NCT05428969 (Principal Investigator)
-
Jokke HannukselaSeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Kimmo PorkkaSeen in:
- Helsinki, Helsinki University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Kirsi LaunonenSeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Maija Itälä-Remes, Prof. Dr.Seen in:
- Turku, Turku University Central Hospital
Trials:- NCT04232241 (Principal Investigator)
-
Manna MiilunpohjaSeen in:
- Kuopio, Kuopio University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Marja PyöräläSeen in:
- Kuopio, Kuopio University Hospital
Trials:- NCT05428969 (Principal Investigator)
-
Marjaana SäilySeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Merja MöttönenSeen in:
- Oulu, Department of Pediatrics, Oulu University Hospital
Trials:- NCT01828489 (Principal Investigator)
Conditions: -
Mika KontroSeen in:
- Helsinki, FI-Helsinki-HUS
- Helsinki, Helsinki University Hospital
Trials:- NCT04027309 (Principal Investigator)
- NCT05428969 (Principal Investigator)
-
Mikko ArolaSeen in:
- Tampere, Department of Pediatrics, Tampere University Central Hospital
Trials:- NCT01828489 (Principal Investigator)
Conditions: -
Mikko MyllymäkiSeen in:
- Helsinki, Helsinki University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Milla KuusistoSeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Minna KoskenvuoSeen in:
- Turku, Department of Pediatrics, Turku University Central Hospital
Trials:- NCT01828489 (Principal Investigator)
Conditions: -
Pekka RiikonenSeen in:
- Kuopio, Department of Pediatrics, Kuopio University Hospital
Trials:- NCT01828489 (Principal Investigator)
Conditions: -
Perttu KoskenvesaSeen in:
- Helsinki, Helsinki University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Riikka RätySeen in:
- Helsinki, Helsinki University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Sakari KakkoSeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Samppa Ryhänen, MD, PhDSeen in:
- Helsinki, Division of Hematology, Oncology, and Stem Cell Transplantation, The New Children's Hospital, Helsinki University Hospital
Trials:- NCT05477589 (Principal Investigator)
-
Sari KytöläSeen in:
- Helsinki, Helsinki University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Sari LuopajärviSeen in:
- Tampere, Tampere University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Sirpa KoskelaSeen in:
- Tampere, Tampere University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Taru KuittinenSeen in:
- Kuopio, Kuopio University Hospital
Trials:- NCT05428969 (Sub-Investigator)
-
Timo SiitonenSeen in:
- Oulu, Oulu University Hospital
Trials:- NCT05428969 (Principal Investigator)
-
Urpu Salmenniemi, Prof. Dr.Seen in:
- Turku, Turku University Central Hospital
Trials:- NCT04232241 (Sub-Investigator)
Clinical Trials on Leukemia, Myeloid, Acute
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Advesya SASNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryFrance, Sweden, Spain, Germany